Published in Medical Device Law Weekly, February 27th, 2005
The Madison-based company said it increased the reserve to $21.1 billion for fen-phen payouts and legal costs, from $17 billion last year, of which $7.2 billion remains.
For the first time, the company believes that the remainder represents the "best estimate" of the total remaining cost of the litigation, said Robert Essner, Wyeth's chairman, president and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.